Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Germs|January 17, 2014
Tuberculous empyema presenting as a persistent chest wall mass: case reportJennifer Madeo, Rinal Patel, Wondwossen Gebre, et al.
The Pediatric Infectious Disease Journal|December 8, 2022
The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure InfectionsManana Giorgobiani, Margaret H Burroughs, Tinatin Antadze, et al.
Molecular Carcinogenesis|December 6, 2008
The human promyelocytic leukemia protein is a tumor suppressor for murine skin carcinogenesisVictoria M Virador, Rafael E Flores-Obando, Adam Berry, et al.
Trials|May 16, 2022
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trialNicholas A Turner, Smitha Zaharoff, Heather King, et al.
American Heart Journal|April 17, 2025
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trialThiago Gagliano-Jucá, Karol M Pencina, Yili V Shang, et al.
JAMA Network Open|April 18, 2026
Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical TrialThomas P Lodise, Nicholas A Turner, Toshimitsu Hamasaki, et al.
JAMA|August 13, 2025
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical TrialNicholas A Turner, Toshimitsu Hamasaki, Sarah B Doernberg, et al.
Pageof 1